PLANETS
27.9.2021 18:02:10 CEST | Business Wire | Press release
teamLab Planets TOKYO in Toyosu, Tokyo welcomes “Vegan Ramen UZU Tokyo ” from Kyoto; a new artwork space; and a flower shop where visitors can take home the orchids used in one of the museum’s artworks. “Vegan Ramen UZU Kyoto” opened in Kyoto in March of 2020, becoming hugely popular with hour-long wait times. At “Vegan Ramen UZU Tokyo,” vegan ramen can be enjoyed in the Reversible Rotation - Non-Objective Space or Table of Sky and Fire artwork spaces.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210927005038/en/
There will also be a new flower shop, “teamLab Flower Shop & Art,” where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One , in which visitors become one with over 13,000 orchids. All of these facilities open on Friday, October 8 to the public, not just to teamLab Planets museumgoers.
Vegan Ramen UZU Tokyo
: https://vegan-uzu.com/pages/uzu-tokyo-en
teamLab Planets
Museum Details: planets.teamlab.art
teamLab Planets
Highlight Video: https://youtu.be/xofyyJYYWMY
[Vegan Ramen UZU]
At "Vegan Ramen UZU Kyoto,” which opened in March of 2020 in Gosho-Minami, Kyoto, teamLab was responsible for designing the space and other aspects of the restaurant, where guests can enjoy vegan food while surrounded by art.
“Vegan Ramen UZU Tokyo ,” which will open at teamLab Planets , will have vegan ramen available for takeout, as well as to enjoy at the newly-opened Reversible Rotation - Non-Objective Space and Table of Sky and Fire artwork spaces. Flower Vegan Ramen, Green Tea Vegan Ramen, and Vegan Ice Cream will also be available only at “Vegan Ramen UZU Tokyo.”
Official Website: https://vegan-uzu.com/
Media Coverage of “Vegan Ramen UZU Kyoto”
-
Time Out
“teamLab has designed a vegan ramen restaurant in Kyoto”
https://www.timeout.com/tokyo/news/teamlab-has-designed-a-vegan-ramen-restaurant-in-kyoto-012021
Vegan Ramen Menu
- Soy Sauce Vegan Ramen
- Miso Vegan Ramen (Spicy)
[Vegan Ramen UZU Tokyo Only Menu]
- Green Tea Vegan Ramen
- Flower Vegan Ramen (Cold)
[New Public Artworks]
Reversible Rotation - Non-Objective Space
teamLab, 2021, Digital Installation, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/reversiblerotation_nonobjective/
The artwork space is freed from the physical boundaries of the surfaces of tables or chairs.
The Spatial Calligraphy rotates in the artwork space, every aspect rotating in the same direction. But because of the special characteristics of Ultrasubjective Space, it can appear to be rotating clockwise or counterclockwise.
Spatial calligraphy is calligraphy drawn in space, a form of calligraphy that teamLab has been exploring since it was founded. The artwork reconstructs calligraphy in three dimensional space to express the depth, speed and power of the brush stroke, and that calligraphy is then flattened using the logical structure teamLab calls ultrasubjective space. The calligraphy shifts between two and three dimensions.
Table of Sky and Fir
e
teamLab Architects, 2021
Artwork: https://planets.teamlab.art/tokyo/ew/tableskyfire_planets/
This table reflects the sky and the Universe of Fire Particles Falling from the Sky. The table is connected to the artwork and to the sky.
Human beings need to be connected to the world to live. teamLab hopes that people will eat something on this table while thinking that to live and to eat is to stay connected to the world.
[teamLab Flower Shop & Art]
This is a flower shop where visitors can take home orchids used in the artwork Floating Flower Garden: Flowers and I are of the Same Root, the Garden and I are One (photo above), in which visitors become one with over 13,000 orchids.
Orchids live on even after the flowers have fallen, blooming again and again, sometimes for decades. In order for people to take home a part of the work, we sell tote bags containing a variety of orchids. Those who wish to purchase orchids separately may do so from a more limited selection of orchid species.
[teamLab Planets ]
teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.
By immersing the entire body with other people in these massive body immersive artworks, the boundary between the body and the artwork dissolves, the boundaries between the self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.
Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.
[Summary]
Vegan Ramen UZU Tokyo
https://vegan-uzu.com/pages/uzu-tokyo-en
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:30 - 20:00
Sundays 10:30 - 19:00
Closed: same as closed days for teamLab Planets
teamLab Flower Shop & Art
Open Hours:
October
Mondays - Fridays 11:00 - 19:00
Saturdays 10:00 - 20:00
Sundays 10:00 - 19:00
Closed: same as closed days for teamLab Planets
teamlab Planets TOKYO
https://planets.teamlab.art/tokyo/
#teamLabPlanets
Term:
July 7, 2018 - End of 2022
Venue:
teamLab Planets TOKYO (6 Chome-1-16 Toyosu, Koto City, Tokyo
)
Hours:
September: Mon - Fri 10:00 - 20:00 / Sat, Sun, Holidays 9:00-20:00
October: Mon - Fri 10:00 - 19:00 / Sat 9:00 - 20:00 / Sun 9:00 - 19:00
* Last entry 1 hour before closing
Closed:
October 5
Admission:
[Entrance Pass]
Adults (ages 18 and older): JPY 3,200
University / Trade School Students: JPY 2,500
Middle School / High School Students: JPY 2,000
Children (ages 4 - 12): JPY 300
Infants (ages 3 and younger): Free
Seniors (ages 65 and older): JPY 2,400
Visitors with Disabilities: JPY 1,600
teamLab Planets TOKYO
Ticket Store: https://teamlabplanets.dmm.com/en
* Admission and exhibition hours are subject to change. Please check the official website for the latest information.
* A separate admission fee is required for the newly-opened artwork space Reversible Rotation - Non-Objective Space
. This space is also open to visitors other than teamLab Planets
museumgoers.
Official Social Media Pages:
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
Measures Against the Spread of COVID-19:
Infection prevention measures such as entry restrictions are being implemented. Please check the website for details.
https://teamlabplanets.dmm.com/en/covid-19
[Press Kit]
https://goo.gl/tQXMLm
[Media Inquiries]
https://goo.gl/forms/fqn8DmGV8WWIntP53
[PLANETS Co., Ltd.]
The managing entity for facilities operations at teamLab Planets TOKYO
Address: Tokyo Nihonbashi Tower 26F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
[About teamLab]
teamLab (f. 2001) is an international art collective, an interdisciplinary group of various specialists such as artists, programmers, engineers, CG animators, mathematicians and architects whose collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world.
teamLab aims to explore the relationship between the self and the world and new perceptions through art. In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perception of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.
teamLab has been the subject of numerous exhibitions at venues worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, Taipei, and Melbourne among others. The permanent museums teamLab Borderless opened in Odaiba,Tokyo in June 2018, and teamLab Borderless Shanghai in Huangpu District, Shanghai in November 2019. teamLab Planets , a museum where you walk through water and a garden where you become one with the flowers in Toyosu, Tokyo is on view until the end of 2022. The large-scale permanent exhibition teamLab SuperNature soft opened in Macao in June, 2020. teamLab’s annual life-work exhibition, VOLVO teamLab: A Forest Where Gods Live , is on view in Mifuneyama Rakuen, Takeo Hot Springs, Kyushu until November 7, 2021.
teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
teamLab is represented by Pace Gallery , Martin Browne Contemporary , and Ikkan Art .
teamLab: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
View source version on businesswire.com: https://www.businesswire.com/news/home/20210927005038/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
